Skip to content

Clinimetric properties of the SMT.

Clinimetric properties of the Spasticity Measurement Tool, an objective measurement instrument to define spasticity in stroke patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25852
Enrollment
32
Registered
2011-03-25
Start date
2011-04-15
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity of stroke patients Spasticiteit bij CVA patienten

Interventions

None listed

Sponsors

Roessingh Research and Development
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for stroke patients are: 1. A history of a single unilateral stroke resulting in hemiparesis with a slight to moderate spasticity in the lower arm; 2. The onset of the stroke was more than three months ago; 3. The patient is above 18 years; 4. Adequate cognitive functions to understand the experiments, follow instructions, and give feedback to the researchers. Inclusion criteria for healthy subjects are: 1. Ability to decide whether or not to participate in the experiment and sign an informed consent; 2. Age and sex matched to the patient group.

Exclusion criteria

Exclusion criteria: Exclusion criteria for both stroke patients and healthy subjects are: 1. A fixed contracture deformity in the (affected) upper limb was present; 2. Suffering of any medical, psychological or cognitive impairment which may have compromised safety or the ability to comply with the protocol.

Design outcomes

Primary

MeasureTime frame
RMS of the EMG, Force and angular velocity.

Secondary

MeasureTime frame
1. PRPM: An ordinal scale derived from the Asworth scale; 2. VAS scale.

Contacts

Public ContactSanne Vis, van der

Roessingh Research and Development Roessinghbleekweg 33b

s.vandervis@rrd.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)